WO2003007960A1 - Method for protecting human skin against infections and a dermatic for carrying out said method - Google Patents

Abstract

The invention relates to medicine and can be used for protecting a human being against bacteria or viral infections. The inventive dermatic is embodied in the form of a soap, shampooing, gel or a cream. Anti-infective preparations for example dioxidine in a liposomal form and in a subtherapeutical dosage, for example ranging from 0.01 to 10.0 mass %, are introduced into said dermatic. For a short while, said dermatic is present on the surface of the horny layer of the skin in an aerobic condition thereof without having any time to harmfully affect the microflora thereof, the remainder of the dermatic being easily washed out of the skin surface. The main mass of the dermatic being embodied in the liposomal form penetrates the epidermis of the skin, whereby the bactericide effect of dioxidine is increased by 10-30 times in an aerobic condition and produces a prolonged and maximal action on the microflora within the thickness of the skin and branches thereof, protecting them against a pyoinflammatory process occurring from the inside. Said invention increases the efficiency of antibacterial agents and reduces the harmful action thereof on the useful resident microflora of the skin.

Description

 The method of protection of the skin of the person from infections and

external equipment for its implementation

5 Area of technology

The invention is available in the field of medicine and may be used.

Used to protect human beings from bacterial or viral

infections.

PREVIOUS LEVEL OF TECHNOLOGY

You are aware of a method of dealing with infections using an

Such a consignment containing an active active substance,

a binder, a distributor and water, as a rule, in the form of an active

sanguine substances used as a binder, binder - polivini-

the left hand side of the distributor is ethanol (Κυ, 2014085).

15 The use of infectious drugs has been reported.

antibacterial device, as a rule, it is used 1 -

cyclo-6-nitro-7 - (4-methyl-pyrazinyl) - 4 oxo 1, 4 - dihydro-

ρ χ ин ин quinoline - 3 carboxylic acid or its hydrous acid (ΚΙ)

2024258).

20 The treatment of viral infections of the skin and mucous membranes has been known.

Conventionally, including the local introduction of the drug gene -

Engineer α ₂ - an interface that is subject to process, which is from the beginning

the essence of the disease on the affected areas of the skin and / or mucous

SIGNIFICANT FOX (DR. 26) In general, a single, simultaneous application of the drug is available at the place

a narrowing concomitant action in combination with 2.5 - 5.0χ 10 ⁵ ΜΕ / ml

Genetic - Engineering α ₂ - Integrated and 2.5 - 5.0χ 10 ⁴ ΜΕ / ml Genetic -

engineer γ - an interface 2–5 times a day in two days

5 depending on the severity of inflammatory events (GE,

2022562).

The method of protecting the human being from infection is known, including

arising from the use of an external device, it is also introduced

Various antibacterial drugs, and, as a rule, active

from the beginning, a 10% emulsion was used, containing 0.1%

alpha-τοκοφеροла (ΡΙΙ, 2036637).

The well-known means of protection of the human being

infections are anti-inflammatory drugs in aerobics

The conditions of access to the middle layer of the skin do not suppress only the pathogen

15 microorganisms, but also a residental beneficial skin,

protecting the skin from the introduction of malignant bacteria, at that time

like in anaerobic conditions effective antibiotic substances

small.

DISCLOSURE OF INVENTION

20 The objective of the invention is to increase the efficiency

Antibacterials in anaerobic conditions under single-use conditions

a decrease in their indirect effect on the resident beneficial microcirculation

skin.

SIGNIFICANT FOX (DR. 26) The task posed is solved due to the fact that there is a way to protect the human being from infection, which is concluded in the use of

In case of emergency, in the case of simple drugs, they are treated in the same way as in the case of drugs

5 on an external basis in a private forum and in a therapeutic dose, I choose from a condition of minimal impact

Ineffective product in aerobic conditions of the outer skin of the skin on its normal body and maximum

Exposure to anaerobic conditions

south of the world in the thick layer of the skin and its features.

Home equipment for the implementation of the declared method, including an effective drug, is damaged, which means that

in the form of a pharmaceutical preparation, an antimicrobial preparation is used from the chynoxaline group.

15 With this, essential essentials are obtained, which ensures the result of technical results in all cases,

The consumer is using the required volume of waste.

Otherwise, the claimed solution has an effective policy.

signs specifying its special cases, its specific forms

20 material incarnations, and specifically:

- as an antimicrobial product, dioxidine may be used,

SIGNIFICANT FOX (DR. 26) - as a part of an antimicrobial preparation, chinoksidin may be used.

- antimicrobial can be introduced in quantities of 0.01 - 10.0 wt.%.

5 The applicants have not established any sources of information that would contain information about the solutions that are identical or

Equivalently stated, the independent functions of the product are subject to the availability of new components of knowledge. That οπρ-

divides the invention into the novelty clause (Ν).

The implementation of the terms of the invention unequivocally determines the appearance of an important technical effect in the user, which is the key

there is an antimicrobial preparation of chinoxaline in

liposomal form and in the substitute, τ. e. less than for

therapies do not disturb the world at the expense of the skin and

15 is the most effective in anaerobic conditions in the worst case.

The receipt of the positive result ensures the appearance of the invention in a whole a series of useful features, and in particular, from below

reduction in fatalities of the skin, as well as a reduction in the risk of falling into the environment and high

20 EFFECTIVENESS OF SECURITY PROTECT FROM ALL KINDS OF INFECTION

Indicated disclaimer of declared technical data

the corresponding ruling “inventive step” (15).

SIGNIFICANT FOX (DR. 26) BEST MODE FOR CARRYING OUT THE INVENTION

Β external substance in the form of soap, shampoo, gel or cream

introduces drugs, for example, dioxidine, in private and in patient care, for example,

5 0.01 to 10.0 wt.%. They specify the cost of the device depending on the selected antimicrobial product, the equipment and the properties of the medical device.

Β aerobic conditions of the working environment of the middle layer of the leather

The main external device is short-lived and does not accelerate the external

You can affect its external area of the body, and its quickness is washed away from the skin. The main mass of the external medium, for

due to the physical form penetrates deep into the epidemic, where in anaerobic conditions, the bactericidal effect of dioxidine increases

at 10-30 times, which results in maximum and maximum effect

15 trivial impact on the microcosm in the general layer of the skin and its

overs, protecting them from the recognition of the gnome-inflammation process

exhausted.

A short time before the location of the declared external home

Immediate rescue of the skin does not allow microorganisms to gain stability in antimicrobial treatment. Essential πρ-

the property declared is also that the antimicrobial is used in small substrates, which are mini

minimizes the risk of falling into the patient’s area.

SIGNIFICANT FOX (DR. 26) Intended use.

The invention may be practiced using

home appliances and supplies. Let us give an example of practical implementation of the declared solutions.

5 EXAMPLE 1. Bolny P. 22 years. In the course of the year, the general

Furunculosis. The general benefit of the positive results did not improve, every 3-4 months new features appeared. After the use of 2 times a week of soap, it is made in accordance with

the declared method containing dioxidine in the physical group and in the subsidiary dosage, the manifestation of new drugs is not

It was noted during the course of the year.

Example 2. Bologna льн. 56 years He became vulgar in the course of 2 years. The generalized therapy of the effect did not produce. Disease

every 3-4 months, recurrence. After the application

15 life-threatening dioxidine in the lipid form and in the substitute

On the other hand, there was a clinical recovery, and recurrence of the disease during the course of the year was not observed.

The invention ensures an increase in the efficiency of the anti-bacterial system due to a decrease in its indirect effect on

20 Residential Useful Skin.

SIGNIFICANT FOX (DR. 26)

Claims

Formula of the invention 1. The method of protecting the skin of a person from infection, including in the use of the external means, in addition to it, the direct Optional drugs, which are different from those that are infectious. 5 other drugs enter the external environment in the private area and in the substitute dose, I choose from the condition minimal exposure to the drug in the airport current conditions of the residency of the living in the middle of her micro-occupation and maximum occupation of an infectious infection In the case of anaerobic conditions on the microcircuit, generally speaking, her pride 2. Other means, including direct infection The product is characterized by the fact that, as a standard, it is infectious The preparation was used antimicrobial preparation from the group of chinoxal 15 on. 3. Medium π 2, which is different from the quality of anti- A large quantity of the drug used is dioxidine. 4. Mediocre p. 2, differing in that, as a rule, anti- a small preparation was used chinoxidine. 20 5. Medium of any of π.π. 2-4, which is different from a similar product from the group of chinoxaline introduced in quantities of 0.01 - 10.0 ac.%. ZΑΜΕΗYAU IJ LISΤ PΡΑΒILΟ 26